{"version":"1.0","provider_name":"Site da Brakke Consulting","provider_url":"https:\/\/brakkeconsulting.com\/pt","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"k7DJUsQsqO\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-december-3-2021\/\">Brakke Viewpoint 3 de dezembro de 2021<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-december-3-2021\/embed\/#?secret=k7DJUsQsqO\" width=\"600\" height=\"338\" title=\"\u201cBrakke Viewpoint 3 de dezembro de 2021\u201d - Site da Brakke Consulting\" data-secret=\"k7DJUsQsqO\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"The hot acquisition market in animal health seems to be continuing apace.\u00a0 There have been over 130 acquisitions noted in our newsletter through November of this year \u2013 with another 5 in this newsletter alone \u2013 and there are no doubt some we have missed. Growth through acquisition seems to be a primary focus for many animal health companies large and small. \u00a0In addition, private equity and other outside investors are paying impressive multiples to get into the animal health game. \u00a0Most of these recently have been smaller, more strategic purchases. But now that the dust has settled from the Elanco\/Bayer merger, is it possible there is another mega-merger in the offing?\u00a0 Only time will tell. Lynn Fondon YOUR VIEW Last week we asked if you thought there will be a mega-merger in animal health in 2022 and a majority (56%) said no. A few respondents left responses with their merger candidates, but we\u2019ll keep them under wraps \u2013 don\u2019t want to start rumors!"}